Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

VILTEPSO (viltolarsen) for the Treatment of Duchenne Muscular Dystrophy (DMD)

Image 1-VILTEPSO (viltolarsen)
VILTEPSO (viltolarsen) injection is the second FDA-approved targeted treatment for patients with DMD after Sarepta’s Vyondys 53 (golodirsen) injection. Credit: NS Pharma, Inc.